Muscle Tightness: A Fall Risk Factor?

could tightness of muscle cause falls

Muscle tightness and weakness can be caused by several factors, including ageing, muscle atrophy, and certain diseases. These factors can increase the risk of falls, which can lead to injuries and hospitalizations. For example, sarcopenia, a condition that commonly affects the elderly, is characterized by the gradual loss of muscle mass, strength, and function, resulting in frailty and an increased risk of falls. Similarly, stiff person syndrome (SPS) can cause muscle spasms and stiffness, leading to unsteadiness and an increased risk of falling. Other factors, such as muscle fatigue, dizziness, and alcohol consumption, can also contribute to falls. Understanding these risk factors is crucial for fall prevention and maintaining overall health.

Characteristics Values
Muscle tightness Stiff Person Syndrome (SPS), Sarcopenia, Muscular Dystrophy
Causes Spasms, Muscle atrophy, Localised muscle fatigue
Risk factors Ageing, Loss of consciousness, Alcohol, Bladder or bowel conditions, Dizziness, Foot problems
Symptoms Muscle weakness, Poor balance, Clumsiness, Delayed development, Frequent falls
Treatments Immune-based therapies, Exercises

cyvigor

Muscle weakness and falls in older adults

Muscle weakness is a significant risk factor for falls in older adults. As people age, their muscles gradually weaken, affecting their strength, balance, and coordination. This muscle weakness can lead to an increased risk of falling, particularly in older adults who may already have balance issues or difficulty walking.

Several conditions can contribute to muscle weakness in older adults. Sarcopenia, for example, is a common condition characterised by the gradual loss of muscle mass, strength, and function due to ageing. The condition primarily affects older individuals, with a more rapid decline in muscle mass typically occurring between the ages of 65 and 80. Sarcopenia can significantly impact an individual's quality of life, leading to increased frailty, falls, and fractures. It is associated with a higher risk of hospitalisation and surgery, which can increase the likelihood of complications, including death.

Muscular dystrophy is another condition that can cause muscle weakness and increase the risk of falls. It encompasses a group of over 30 diseases that lead to muscle weakness and wasting. While some types of muscular dystrophy present in early childhood, others, such as Emery-Dreifuss muscular dystrophy, may have an onset around age 10, affecting mobility and muscle strength.

Additionally, ageing-related hormonal changes, such as decreases in testosterone and insulin-like growth factor (IGF-1), can also contribute to muscle weakness in older adults. These hormonal changes can lead to sarcopenia and subsequent muscle weakness, further elevating the risk of falls.

The risk of falling due to muscle weakness can be mitigated through various interventions. While the literature does not strongly support the idea that muscle-strengthening exercises prevent falls, they may still be beneficial. Clinical trials are needed to determine the effectiveness of muscle-strengthening exercises in fall prevention for older adults. Nonetheless, maintaining muscle strength, particularly in the lower extremities, is essential for reducing the risk of falls in older adults.

cyvigor

Stiff Person Syndrome (SPS)

SPS can develop at any age, but it most commonly affects people in their 30s, 40s, and 50s. In rare cases, it can also occur in children and older adults. The first symptom is typically muscle stiffness in the trunk (abdomen, chest, and back muscles). Over time, stiffness and spasms can spread to the legs and other muscles, making walking difficult. The spasms can be triggered by unexpected loud noises, physical touch, changes in temperature, and stressful events. Due to these unpredictable triggers, some people with SPS develop anxiety and agoraphobia, as it becomes challenging to avoid triggers in public spaces.

SPS is believed to be an autoimmune disorder, where the body's immune system mistakenly attacks healthy cells. People with SPS often have unique antibodies called anti-GAD65 antibodies, which block the glutamic acid decarboxylase (GAD) enzyme. GAD is crucial for producing gamma-aminobutyric acid (GABA), a neurotransmitter that helps control muscle movement and blocks certain nerve signals. When GABA is not functioning correctly, nerve cells can act abnormally, leading to physical symptoms like muscle spasms and psychological symptoms like anxiety.

While there is no cure for SPS, medications and therapies can help manage symptoms and improve quality of life. Benzodiazepines, muscle relaxants, and other muscle-spasm alleviators can be used to control symptoms. Intravenous immunoglobulin (IVIg) treatment has been found to reduce stiffness and sensitivity to triggers, improving gait and balance in people with SPS.

cyvigor

Sarcopenia (muscle loss)

Sarcopenia, or muscle loss, is the age-related progressive loss of muscle mass, strength and function. The condition predominantly affects the elderly population and is thought to be caused by the natural ageing process. Sarcopenia can significantly impact a person's quality of life, reducing their ability to perform daily tasks and leading to a loss of independence.

The main symptom of sarcopenia is muscle weakness, which can make it difficult to perform everyday activities such as climbing stairs or walking briskly. Other symptoms include loss of stamina, poor balance and falls, and a decrease in muscle size. The rate of muscle loss varies, but it is estimated that people may lose up to 8% of their muscle mass per decade.

The cause of sarcopenia is widely regarded as multifactorial, with several factors contributing to the development of the condition. These factors include neurological decline, hormonal changes, inflammatory pathway activation, physical inactivity, chronic illness, fatty infiltration, and poor nutrition. Obesity, in particular, has been identified as an important risk factor for sarcopenia, with increased fat mass associated with lower muscle quality and accelerated loss of lean body mass.

In terms of treatment, sarcopenia can be managed and potentially reversed through lifestyle changes. Physical activity, specifically progressive resistance-based strength training, can help improve muscle strength and reverse muscle loss. Adopting a healthy diet, with a focus on increasing protein intake, is also recommended. While there are currently no FDA-approved medications for treating sarcopenia, researchers are exploring the potential use of hormone supplements to increase muscle mass.

It is important to note that while sarcopenia is a natural part of ageing, it is not an inevitable consequence. By incorporating strength training and power training into our routines as we age, we can build and maintain muscle mass, thereby slowing down the progression of sarcopenia.

cyvigor

Muscular dystrophy

Some types of muscular dystrophy affect specific muscle groups, such as the hips, shoulders, upper arms, calves, and facial and neck muscles. For example, in Emery-Dreifuss muscular dystrophy, certain joints become stiff, and children may walk on their toes due to stiff tendons in the heels. Limb-girdle muscular dystrophy affects the hip and shoulder muscles, making it difficult to lift the front part of the foot and leading to frequent tripping and falling.

Myotonic muscular dystrophy, also known as Steinert's disease or dystrophia myotonica, is characterised by an inability to relax muscles after contractions. Facial and neck muscles are often the first to be affected, resulting in long, thin faces, drooping eyelids, and swan-like necks. This type of muscular dystrophy can also cause heart rhythm issues, with the heart muscle weakening as the disease progresses.

Facioscapulohumeral muscular dystrophy (FSHD) typically causes muscle weakness in the face, shoulders, and upper arms, with the shoulder blades protruding like wings when the arms are raised. It can also lead to mild hearing loss and difficulty closing the eyelids, resulting in dry eyes.

Congenital muscular dystrophy affects both boys and girls and is apparent at birth or before the age of two. It can cause breathing problems, progressive weakness, curved spine (scoliosis), heart problems, swallowing difficulties, and nutritional issues.

While there is currently no cure for muscular dystrophy, treatments such as medicines, physical and occupational therapy, equipment, surgery, and other procedures can help manage symptoms and slow the progression of the disease. Corticosteroids, for instance, can aid in maintaining muscle strength and slowing the advancement of certain types of muscular dystrophy. However, long-term use of corticosteroids may lead to weight gain and weaker bones, increasing the risk of fractures. Targeted medicines and gene therapies are also used to treat specific types of muscular dystrophy with confirmed gene changes.

cyvigor

Slip-induced falls

As people age, their muscles weaken, affecting their strength and balance, and making them more prone to falls. Sarcopenia, a condition characterised by the gradual loss of muscle mass, strength, and function, commonly affects the elderly and increases their risk of falling.

Muscle fatigue, particularly of the quadriceps and knee extensor muscles, has been identified as a potential risk factor for slip-induced falls. Localised muscle fatigue can delay the response time in recovering from a fall.

The risk of slip-induced falls is also influenced by friction demand characteristics during walking, including task factors such as working pace, turning, and load carrying, as well as footwear dynamics. Poor weather conditions, such as ice or snow, can also increase the risk of slip-induced falls if appropriate precautions are not taken.

Additionally, certain medical conditions, such as muscular dystrophy, can cause muscle stiffness and weakness, increasing the risk of falls. It is important to address muscle weakness and take preventive measures to reduce the risk of slip-induced falls, especially among older adults.

Frequently asked questions

Stiff person syndrome (SPS) is a condition that causes muscle contractions, spasms, and rigidity. It can lead to difficulty walking, a stiff or rigid posture, unsteadiness, and falling. SPS can also cause shortness of breath if it affects the chest muscles and may result in spinal cord compression due to changes in spine alignment.

Muscle weakness, especially in the lower extremities, is a significant risk factor for falls, especially in older adults. Sarcopenia, or muscle atrophy, commonly affects older individuals and can lead to a loss of independence and an increased risk of falls and fractures. Poor balance, dizziness, and the use of certain medications can also increase the likelihood of falling.

Localized muscle fatigue, particularly in the quadriceps and knee extensor muscles, has been identified as a potential risk factor for slip-induced falls. Fatigue delays the response time in producing an effective joint moment and base of support to recover from a fall. Additionally, certain occupations that demand intense physical work, such as construction and forestry, can contribute to muscle fatigue and increase the likelihood of slip-induced falls.

Written by
Reviewed by

Explore related products

Share this post
Print
Did this article help you?

Leave a comment